VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,605,420 | -11.1% | 210,139 | +0.6% | 0.05% | -9.1% |
| Q2 2023 | $6,308,387 | -19.8% | 208,916 | -14.1% | 0.06% | -26.7% |
| Q1 2023 | $7,866,672 | +1542.8% | 243,172 | +52.1% | 0.08% | +212.5% |
| Q4 2022 | $478,861 | -85.1% | 159,916 | -93.0% | 0.02% | -35.1% |
| Q3 2022 | $3,221,000 | -61.8% | 2,272,732 | +638.9% | 0.04% | -50.7% |
| Q2 2022 | $8,422,000 | -43.6% | 307,592 | -20.9% | 0.08% | -34.2% |
| Q1 2022 | $14,922,000 | +25.4% | 389,090 | -37.1% | 0.11% | +26.7% |
| Q4 2021 | $11,899,000 | -31.1% | 619,035 | +3.4% | 0.09% | -18.2% |
| Q3 2021 | $17,264,000 | +36.9% | 598,897 | -10.8% | 0.11% | 0.0% |
| Q2 2021 | $12,611,000 | +8.5% | 671,084 | +32.2% | 0.11% | -0.9% |
| Q1 2021 | $11,627,000 | -6.1% | 507,757 | +47.0% | 0.11% | -14.0% |
| Q4 2020 | $12,385,000 | -0.5% | 345,302 | +5.1% | 0.13% | -20.4% |
| Q3 2020 | $12,445,000 | +4.2% | 328,649 | +0.9% | 0.16% | -2.4% |
| Q2 2020 | $11,946,000 | +80.3% | 325,688 | +13.3% | 0.17% | +36.1% |
| Q1 2020 | $6,624,000 | -19.1% | 287,480 | +2.8% | 0.12% | -3.9% |
| Q4 2019 | $8,188,000 | -7.3% | 279,642 | -14.9% | 0.13% | -7.3% |
| Q3 2019 | $8,833,000 | +41.9% | 328,467 | +34.8% | 0.14% | +21.2% |
| Q2 2019 | $6,226,000 | +46.3% | 243,588 | +28.3% | 0.11% | +34.5% |
| Q1 2019 | $4,256,000 | +16.0% | 189,882 | +9.0% | 0.08% | -4.5% |
| Q4 2018 | $3,670,000 | +17.0% | 174,226 | +2.8% | 0.09% | +37.5% |
| Q3 2018 | $3,138,000 | +7.2% | 169,456 | +28.2% | 0.06% | +33.3% |
| Q2 2018 | $2,926,000 | +108.1% | 132,169 | +107.1% | 0.05% | -12.7% |
| Q1 2018 | $1,406,000 | -15.6% | 63,830 | -10.2% | 0.06% | -21.4% |
| Q4 2017 | $1,665,000 | -34.2% | 71,097 | -33.3% | 0.07% | +11.1% |
| Q3 2017 | $2,529,000 | +73.5% | 106,574 | +57.3% | 0.06% | +61.5% |
| Q2 2017 | $1,458,000 | -37.4% | 67,762 | -31.7% | 0.04% | -40.0% |
| Q1 2017 | $2,328,000 | -18.1% | 99,229 | -22.7% | 0.06% | -30.1% |
| Q4 2016 | $2,843,000 | +9.6% | 128,298 | +19.2% | 0.09% | -12.3% |
| Q3 2016 | $2,595,000 | -24.7% | 107,661 | -4.5% | 0.11% | -23.7% |
| Q2 2016 | $3,446,000 | – | 112,745 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |